Please login to the form below
New president for Spanish Society of Pharmacology
Maria Jesús Sanz is a professor of pharmacology at the University of Valencia
The Spanish Society of Pharmacology (SEF) has named Maria Jesús Sanz as its new president.
Jesús Sanz, a professor of pharmacology at the University of Valencia, was elected to the role at the Society's annual meeting in Madrid. He replaces Teresa Tejerina.
Jesús Sanz has over 25 years' experience as a teacher and researcher and has studied in the UK and Canada. His research focuses on the study of inflammatory processes, mediators, leukocyte-endothelium interactions and leukocyte infiltration in various pathologies.
In his new role Jesús Sanz will lead the SEF in its mission to become a forum for people in Spain who are interested in pharmacology and medicine. He will also promote international relations for Spanish researchers and work to improve the Society's relationship with the pharma industry.
Featured jobs
-
Business Director
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Account Director
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
-
Senior Account Manager
-
Competitive Salary Offered
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
- Account Manager / Senior Account Manager
-
35, 000-40, 000
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
